AMGN Jan 2025 330.000 call
| Previous close | 18.90 |
| Open | 23.10 |
| Bid | 21.00 |
| Ask | 21.50 |
| Strike | 330.00 |
| Expiry date | 2025-01-17 |
| Day's range | 22.75 - 23.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.76k |
ZacksAmgen (AMGN) Ascends While Market Falls: Some Facts to Note
Amgen (AMGN) closed at $322.67 in the latest trading session, marking a +1.12% move from the prior day.
BloombergRegeneron Shares Head for Worst Month Since 2019 on Legal Ruling
(Bloomberg) -- Regeneron Pharmaceuticals Inc. shares are headed for their biggest monthly drop since mid-2019 after a legal setback that opens the door to an early launch of a competing therapy to the drugmaker’s blockbuster eye treatment, Eylea.Most Read from BloombergClimate Migrants Stand to Overwhelm World’s MegacitiesVanderbilt Leases Struggling NYC Seminary for Campus ExpansionNew Rowhouses in London That Offer a Bridge to the 19th CenturyNJ Transit, Amtrak Trains Delayed After Derailment
Insider MonkeyAmgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts
We recently compiled a list of the 10 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other undervalued wide moat stocks. The US economy was able to pass its first soft-landing test by exhibiting resilience through the […]
